Sub menu

Table. Catch-up schedule for people ≥10 years of age (for vaccines recommended on a population level)

See Catch-up schedules for people ≥10 years of age for more details.

Antigen	Doses needed	Minimum interval between doses	Notes
Diphtheria and tetanus	3 doses	Between doses 1 and 2: 4 weeks Between doses 2 and 3: 4 weeks	People should receive 1 of the doses as dTpa-containing vaccine and complete the course with dT. This dose would also provide the catch-up dose for pertussis. If dT is not available, use dTpa or dTpa-IPV for all 3 primary doses.
Pertussis	1 dose	Not required	People ≥10 years of age who did not receive all the pertussis vaccine doses recommended before the age of 10 years only need 1 dose to be considered up to date. This is regardless of the number of previous doses they received before the age of 10 years. A booster dose of pertussis-containing vaccine is routinely recommended for all adolescents aged 11–13 years. Take this into account when planning catch-up for pertussis.
Hepatitis B, if aged 10–19 years	3 paediatric doses	Between doses 1 and 2: 1 month Between doses 2 and 3: 2 months	Minimum interval between dose 1 and dose 3 is 4 months.
Hepatitis B, if aged 11–15 years only	2 adult doses	4 months	None
Hepatitis B — if aged ≥20 years	3 adult doses	Between doses 1 and 2: 1 month Between doses 2 and 3: 2 months	Minimum interval between dose 1 and dose 3 is 4 months. Some people who are immunocompromised are recommended to receive extra doses or vaccines with higher antigen content.
Poliomyelitis	3 doses	Between doses 1 and 2: 4 weeks Between doses 2 and 3: 4 weeks	None
Human papillomavirus, if started at 9–14 years of age	2 doses	6 months	If there is an interval of <5 months between doses 1 and 2, a 3rd dose is needed at least 12 weeks after the 2nd dose. If there is an interval of <6 months but ≥5 months between doses 1 and 2, a 3rd dose is not needed. People who are immunocompromised need a 3-dose schedule, regardless of age when they start vaccination.
Human papillomavirus, if started at ≥15 years of age	3 doses	Between doses 1 and 2: 4 weeks Between doses 2 and 3: 12 weeks	Minimum interval between dose 1 and dose 3 is 5 months.
Measles, mumps and rubella	2 doses	Between doses 1 and 2: 4 weeks	None
Meningococcal	1 dose of MenACWY vaccine	Not required	The required catch-up dose is specific to routine use of MenACWY vaccine. MenACWY and MenB vaccines are also indicated for people at increased risk of meningococcal disease in alternative schedules. See Meningococcal disease and Vaccination for special risk groups.
Pneumococcal	Depends on person’s age, Aboriginal and Torres Strait Islander status, and whether they have medical condition(s) associated with an increased risk of invasive pneumococcal disease	Varies	See Pneumococcal disease and Vaccination for special risk groups.
Varicella, if aged <14 years	At least 1 dose	Between doses 1 and 2: 4 weeks (if 2nd dose is given)	Recommended for all non-immune people. People aged <14 years are recommended to receive at least 1 and preferably 2 doses. Children aged <14 years can receive MMRV vaccine.
Varicella, if aged ≥14 years	2 doses	4 weeks	2 doses are recommended for all non-immune people aged ≥14 years. MMRV is not recommended for use in people ≥14 years of age.
Zoster	1 dose if aged ≥60 years	Not required	Zoster vaccine is recommended for people aged ≥60 years. Routine vaccination of people aged 70–79 years is particularly recommended because it is expected to provide the greatest benefits against herpes zoster and its complications.
Acronyms used dT =diphtheria-tetanus; dTpa = reduced antigen content diphtheria-tetanus-acellular pertussis; IPV = inactivated poliovirus; MenACWY = meningococcal ACWY; MenB = meningococcal B; MMRV = measles-mumps-rubella-varicella

Page history

Last updated

3 June 2020

Last reviewed

3 June 2020

Printed content may be out of date. For up to date information, always refer to the digital version:

https://immunisationhandbook.health.gov.au/resources/tables/table-catch-up-schedule-for-people-10-years-of-age-for-vaccines-recommended-on-a-population-level

Link, share or bookmark directly to this section of the page.